These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 9840211

  • 1. Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats.
    Han KS, Kim YG, Yoo JK, Lee JW, Lee MG.
    Biopharm Drug Dispos; 1998 Nov; 19(8):493-500. PubMed ID: 9840211
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
    Kim EJ, Kim SO, Lee DH, Lim H, Lee MG.
    Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
    [Abstract] [Full Text] [Related]

  • 3. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J, Kim EJ, Han KS, Chang MS, Lee MG.
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [Abstract] [Full Text] [Related]

  • 4. Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.
    Yu SY, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Lee MG.
    J Pharm Sci; 2003 Aug; 92(8):1592-603. PubMed ID: 12884246
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH, Lee MG.
    Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects.
    Choi YH, Kim SG, Lee MG.
    J Pharm Sci; 2006 Nov 01; 95(11):2543-52. PubMed ID: 16937336
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
    Kim J, Han KS, Lee JW, Lee MG.
    Res Commun Mol Pathol Pharmacol; 1998 Nov 01; 102(2):125-36. PubMed ID: 10100504
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS, Bae SK, Lee MG.
    Int J Pharm; 2006 Aug 31; 320(1-2):64-70. PubMed ID: 16730145
    [Abstract] [Full Text] [Related]

  • 18. Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
    Choi YH, Lee YS, Bae SH, Kim TK, Lee BY, Lee MG.
    Biopharm Drug Dispos; 2009 Sep 31; 30(6):305-17. PubMed ID: 19639551
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.